China Drug Approval Backlog Piling Up Fast
This article was originally published in PharmAsia News
Executive Summary
The addition of over 4,000 further products has pushed China’s drug approval backlog towards the 18,600 mark by the end of 2014, with the massive queue causing renewed concerns in the industry.